Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Today, we will be discussing his insights on two recently introduced health policy legislation aimed at improving telehealth access and expediting lung cancer
Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Can you tell us a little about your professional background and your role as a biopharma expert? Certainly. I have spent the last couple of decades working at
In today’s healthcare landscape, data is more abundant than ever. Hospitals, research institutions, and medical professionals collect vast amounts of information—from patient histories and lab results to imaging scans and clinical trial data. However, the sheer volume and complexity of this data
In a groundbreaking advancement, researchers from Tsinghua University and Beijing Tsinghua Changgung Hospital have developed a new approach called ECG-LM (Electrocardiogram-Large Model) that significantly enhances the interpretation of electrocardiogram (ECG) data for diagnosing heart diseases.
Recent advancements in healthcare are uncovering surprising new uses for existing medications, and one prominent example is Ozempic (semaglutide). Originally hailed for its effectiveness in treating diabetes and aiding in weight loss, Ozempic is now being investigated for its potential to address
Laboratory research has always been at the forefront of scientific innovation, driving breakthroughs in medicine, materials science, and more. Recently, the integration of automation and artificial intelligence (AI) has begun to revolutionize how research is conducted, offering unprecedented
